Paper40908342
Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets.
Ziółkowska EA and 5 others. Nat Rev Neurol, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. Papers, record 40908342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40908342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuronal Ceroid-Lipofuscinoses | Major topic |
| Animals | |
| Humans | |
| Enzyme Replacement Therapy | |
| Tripeptidyl-Peptidase 1 |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 NS126907 | NINDS NIH HHS | United States | R21NS126907 | PubMed | NIH RePORTER |
| R56 NS117635 | NINDS NIH HHS | United States | R56NS117635 | PubMed | NIH RePORTER |
| R01 NS124655 | NINDS NIH HHS | United States | R01NS124655 | PubMed | NIH RePORTER |
| R01 NS140682 | NINDS NIH HHS | United States | R01NS140682 | PubMed | NIH RePORTER |
| R21 NS116574 | NINDS NIH HHS | United States | R21NS116574 | PubMed | NIH RePORTER |
| RM1 NS132962 | NINDS NIH HHS | United States | RM1NS132962 | PubMed | NIH RePORTER |
References219
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36078049 | Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment. | Cells | 2022 | https://conductscience.org/library/papers/36078049 | PubMed |
| 2 | 19046998 | Sorting of lysosomal proteins. | Biochim Biophys Acta | 2009 | https://conductscience.org/library/papers/19046998 | PubMed |
| 3 | 22502604 | Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics. | Brain Res Bull | 2012 | https://conductscience.org/library/papers/22502604 | PubMed |
| 4 | 38211816 | Disruption of lysosomal nutrient sensing scaffold contributes to pathogenesis of a fatal neurodegenerative lysosomal storage disease. | J Biol Chem | 2024 | https://conductscience.org/library/papers/38211816 | PubMed |
| 5 | 4763201 | Infantile type of so-called neuronal ceroid-lipofuscinosis. Histological and electron microscopic studies. | Acta Neuropathol | 1973 | https://conductscience.org/library/papers/4763201 | PubMed |
| 6 | 40367194 | An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and mice. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/40367194 | PubMed |
| 7 | 28506594 | Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis. | Mol Ther | 2017 | https://conductscience.org/library/papers/28506594 | PubMed |
| 8 | 23297359 | Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. | Hum Mol Genet | 2013 | https://conductscience.org/library/papers/23297359 | PubMed |
| 9 | 11727201 | The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. | Am J Hum Genet | 2002 | https://conductscience.org/library/papers/11727201 | PubMed |
| 10 | 37305926 | A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes. | Dis Model Mech | 2023 | https://conductscience.org/library/papers/37305926 | PubMed |
| 11 | 37113550 | Etiology of anxious and fearful behavior in juvenile neuronal ceroid lipofuscinosis (CLN3 disease). | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37113550 | PubMed |
| 12 | 30618709 | Association of GALC, ZNF184, IL1R2 and ELOVL7 With Parkinson's Disease in Southern Chinese. | Front Aging Neurosci | 2018 | https://conductscience.org/library/papers/30618709 | PubMed |
| 13 | 38193346 | Proximity labelling reveals effects of disease-causing mutation on the DNAJC5/cysteine string protein α interactome. | Biochem J | 2024 | https://conductscience.org/library/papers/38193346 | PubMed |
| 14 | 19556463 | A gene network regulating lysosomal biogenesis and function. | Science | 2009 | https://conductscience.org/library/papers/19556463 | PubMed |
| 15 | 37942487 | Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37942487 | PubMed |
| 16 | 33543660 | Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients. | J Child Neurol | 2021 | https://conductscience.org/library/papers/33543660 | PubMed |
| 17 | 31807779 | Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease. | Hum Mol Genet | 2019 | https://conductscience.org/library/papers/31807779 | PubMed |
| 18 | 32597833 | A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32597833 | PubMed |
| 19 | 33930398 | Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/33930398 | PubMed |
| 20 | 35242840 | The Translational Benefits of Sheep as Large Animal Models of Human Neurological Disorders. | Front Vet Sci | 2022 | https://conductscience.org/library/papers/35242840 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978612 | Case Report: A novel deep intronic MFSD8 splice-altering variant causes CLN7 disease through pseudoexon inclusion. | Front Genet | 2026 | https://conductscience.org/library/papers/42978612 | PubMed |
| 42883434 | Biofluid Proteomic Biomarker Discovery in a Large Animal Model of CLN2 Neuronal Ceroid Lipofuscinosis. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42883434 | PubMed |
| 42745943 | Autophagy-lysosomal pathway in neurodegeneration. | Mol Neurodegener Adv | 2026 | https://conductscience.org/library/papers/42745943 | PubMed |
| 42744859 | Batten disease protein CLN8 enables a non-canonical phospholipid synthesis pathway. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/42744859 | PubMed |
| 42490157 | Characterizing enteric pathology in MPS IIIA mice suggests disease-specific vulnerability among lysosomal storage disorders. | JCI Insight | 2026 | https://conductscience.org/library/papers/42490157 | PubMed |
| 42475369 | Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease. | PLoS One | 2026 | https://conductscience.org/library/papers/42475369 | PubMed |
| 42377569 | A CLN8 biallelic missense variant causes epilepsy with severe treatment-resistant psychosis. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42377569 | PubMed |
| 42146456 | In vivo BMAL1 occupancy mapping using MACS-Calling Cards reveals disease-associated retargeting in Cln3 Δex7/8 astrocytes. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146456 | PubMed |
| 42034784 | Antibiotic treatment reveals the contributions of the gut microbiome to CLN2 disease in the central and enteric nervous system. | Sci Rep | 2026 | https://conductscience.org/library/papers/42034784 | PubMed |
| 41977268 | Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977268 | PubMed |
| 41890119 | Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease. | bioRxiv | 2026 | https://conductscience.org/library/papers/41890119 | PubMed |
| 41782446 | Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/41782446 | PubMed |
| 41466111 | Limited therapeutic efficacy of N-acetyl-L-leucine in a mouse model of CLN1 disease. | Sci Rep | 2025 | https://conductscience.org/library/papers/41466111 | PubMed |
| 41430350 | Enteric nervous system degeneration in human and murine CLN3 disease, is ameliorated by gene therapy in mice. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/41430350 | PubMed |
| 41373441 | GAMT Deficiency: Clinical Presentation, Treatment, Diagnosis, Animal Models, Preclinical and Clinical Developments. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373441 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40908342
GET https://conductscience.org/api/papers/v1/40908342/references?page=2